Clinical evidence on haemodiafiltration
- PMID: 30281128
- PMCID: PMC6168838
- DOI: 10.1093/ndt/gfy218
Clinical evidence on haemodiafiltration
Abstract
Haemodiafiltration (HDF) combines diffusive and convective solute removal in a single treatment session. HDF provides a greater removal of higher molecular weight uraemic retention solutes than conventional high-flux haemodialysis (HD). Recently completed randomized clinical trials suggest better patient survival with online HDF. The treatment is mainly used in Europe and Japan. This review gives a brief overview of the presently available evidence of the effects of HDF on clinical end points, it speculates on possible mechanisms of a beneficial effect of HDF as compared with standard HD and ends with some perspectives for the future.
Figures
References
-
- Ok E, Asci G, Toz H. et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013; 28: 192–202 - PubMed
-
- Morena M, Jaussent A, Chalabi L. et al. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int 2017; 91: 1495–1509 - PubMed
-
- Mostovaya IM, Blankestijn PJ, Bots ML. et al. Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis. Semin Dial 2014; 27: 119–127 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical